U.S. task force: End routine prostate cancer screening

NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft proposal last October, the U.S. Preventive Services Task Force gave PSA screening a D, for "don't recommend" in healthy men. The reaction was fast and furious ...

New PSA guidelines: what do they mean to you?

NBC's Robert Bazell answers frequently asked questions about the latest panel recommendation regarding the popular test that screens for prostate cancer.